That it is the sense of the House of Representatives that Congress should protect Medicare or Veterans’ Administration benefits for medical device treatments for male incontinence and impotence that result from treatment for prostate cancer, diabetes, cardiovascular disease, Parkinson’s disease, or multiple sclerosis and that any such coverage decisions should be based on data and made after careful review by medical experts with a critical eye toward the impact of coverage decisions on the Medicare and Veterans’ Administration populations.